Jinhai Ren
Hebei Key Laboratory Of Hematology
Shijiazhuang, China
Shijiazhuang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Enhanced prognosis of acute myeloid leukaemia patients with dmCEBPAbZIP -inf mutations: Insights from a multicentre Chinese cohort study.
Journal: British journal of haematology
Published: May 22, 2026
Orelabrutinib versus chemoimmunotherapy in treatment-naïve chronic lymphocytic leukemia/small lymphocytic lymphoma: a randomized, phase 3 trial.
Journal: Signal transduction and targeted therapy
Published: December 23, 2025
The characteristics and prognostic analysis of therapy-related acute myeloid leukemia patients in China.
Journal: Science China. Life sciences
Published: November 24, 2024
Expert consensus on a multidisciplinary approach for the management of multiple myeloma-related bone disease.
Journal: Cancer pathogenesis and therapy
Published: September 02, 2024
PTBP1 is a potential indicator of disease progression in acute myeloid leukemia.
Journal: Journal of investigative medicine : the official publication of the American Federation for Clinical Research
Published: July 31, 2024
SUMO-specific protease 1 exacerbates acute myeloid leukemia by enhancing beclin 1-dependent autophagy through polypyrimidine tract-binding protein 1 deSUMOylation.
Journal: Journal of leukocyte biology
Published: February 21, 2024
miR-342-3p Inhibits Acute Myeloid Leukemia Progression by Targeting SOX12.
Journal: Oxidative medicine and cellular longevity
Published: July 12, 2022
2021 Chinese consensus on the diagnosis and management of primary immune thrombocytopenia in pregnancy.
Journal: Chinese medical journal
Published: June 22, 2022
Effect of decitabine and thalidomide on the immunological effect and bone marrow mesenchymal stem cells of patients with myelodysplastic syndrome.
Journal: American journal of translational research
Published: June 11, 2020
Ribophorin II is upregulated in myelodysplastic syndromes and prevents apoptosis and cell cycle progression.
Journal: Experimental biology and medicine (Maywood, N.J.)
Published: May 26, 2020
Decitabine shows anti-acute myeloid leukemia potential via regulating the miR-212-5p/CCNT2 axis.
Journal: Open life sciences
Published: March 05, 2020
Decitabine promotes apoptosis in mesenchymal stromal cells isolated from patients with myelodysplastic syndromes by inducing reactive oxygen species generation.
Journal: European journal of pharmacology
Published: April 20, 2019
Last Updated: 09/26/2026